Recovery from Heart Failure with Circulatory Assist: A Working Group of the National, Heart, Lung, and Blood Institute

Journal of Cardiac Failure

Volumn 9, Issue 6, 2003, Pages 459-463

  Reinlib, Leslie ^a,c   Abraham, William ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Circulatory assist; Devices; Heart failure; LVAD; Mechanical circulatory support

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ASSISTED CIRCULATION; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; HEART FAILURE; HEART FUNCTION; HEART SURGERY; HEART TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

EID: 0347595492     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(03)00592-X     Document Type: Article

References (32)

1. O'Connell JB. The economic burden of heart failure. Clin Cardiol 2000;23:1116-10.
2. Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Failure 1999;1:251-7.
3. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 1994;89:2908-14.
4. Saltzberg S, Lachat M, Zund G, Oechslin E, DeBakey M, Turina M. Left ventricular assist devices as bridge to heart transplantation-lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardiothoracec Surg 2003;24:113-8.
5. Abstracts of the International Society for Heart and Lung Transplantation: Twenty-First Annual Meeting and Scientific Sessions. JHL Trans 2001;20:149-263.
6. Abstracts from the Scientific Sessions 2001. Circulation 2001;104:111-839.
7. Abstracts from the Scientific Sessions 2002. Circulation 2002;106:111-766.
8. Yacoub M. Oral Presentation at the Sixth Annual Scientific Meeting of the HFSA, Boca Raton, Florida, September 22-25, 2002.
9. Hon JK, Yacoub M. Bridge to recovery with use of left ventricular assist device and clenbuterol. Ann Thorac Surg 2003;75(Suppl):S36-41.
10. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
11. Massie BM. Comment. LVADs as long-term cardiac replacement: Success but on what terms and at what cost? J Card Fail 2002;8:61-2.
12. Thoratec Provides Update on Destination Therapy Cost Data. Thoratec Corporation, Investor Relations, Pleasantville, CA; November 21, 2002.
13. Hunt S. Comment. The REMATCH Trial. J Card Fail 2002;8:59-60.
14. Frazier OH. New technologies in the treatment of severe cardiac failure: the Texas Heart Institute Experience. Ann Thor Surg New 1995;59:S31-8.
15. Richenbacher WE. Recovery of myocardial function with long-term ventricular assist device support. ASAIO J 2001;47:586-7.
16. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 1999;100:1189-1193.
17. Kubota T, Miyagishima M, Alvarez RJ, Korinos R, Rosenblum WD, Demetris AJ, et al. Expression of pro-inflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000;19:819-24.
18. Corry DC, DeLucia A 3rd, Zhu H, Radcliffe RR, Brevetti GR, El-Khatib H, et al. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J 1998;44:M347-51.
19. Razeghi P, Mukhopadhyay M, Myers TJ, Williams JN, Moravec CS, Frazier OH, et al. Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg 2001;72:2044-50.
20. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002;346:1357-65.
21. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 2002;8(Suppl):S500-5.
22. Chen Y, Park S, Li Y, Missov E, Hou M, Han X, et al. Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Physiol Genom. In press.
23. Blaxall BC, Tschannen-Moran BM, Milano CA, Kock WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 2003;41:1096-106.
24. Depre C, Davies PJ, Taegtmeyer H. Transcriptional adaptation of the heart to mechanical unloading. Am J Cardiol 1999;83:58H-63H.
25. Westaby S, Katsumata T, Houel R, Evans R, Pigott D, Frazier OH, et al. Jarvik 2000 heart: potential for bridge to myocyte recovery. Circulation 1998;98:1568-74.
26. Siegenthaler MP, Martin J, Frazier OH, Beyersdorf F. Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique. Eur J Cardiothorac Surg 2002;21:546-8.
27. Westaby S, Banning AP, Jarvik R, Frazier OH, Pigott DW, Jin XY, et al. First permanent implant of the Jarvik 2000 Heart. Lancet 2000;356:900-3.
28. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
29. Dib N, McCarthy P, Campbell A, Dinsmore J, Yeager M, Paganin FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Interim results from the United States experience. Circulation 2002;106(Suppl II):II-463. (abstr)
30. Perin EC, Geng Y-J, Willerson JT. Adult stem cell therapy in perspective. Circulation 2003;107:935-8.
31. Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21.
32. Heartmate LVAD clinical results, March 2002, pages 1-7. Thoratec Corporation, Pleasanton. California. Available from: http://thoratec.com/medical-professionals/pdf/Thoratec_VAD_Clinical_Result.pdf. Accessed November 5, 2003.